Related by context. All words. (Click for frequent words.) 73 PNP inhibitor 73 CEQ# 71 treat chronic sinusitis 70 FOLOTYN ® 70 intranasal formulation 70 IL# PE#QQR 70 Aviptadil 70 orally administered inhibitor 70 RNAi therapeutic targeting 70 Liprotamase 70 Squalamine 70 ALN TTR 70 humanized monoclonal 69 PEGylated Fab fragment 69 diarrhea predominant irritable 69 non alcoholic steatohepatitis 69 pan HDAC inhibitor 69 acetonide FA 69 Phase #b/#a clinical 69 Investigational Treatment 69 Ecallantide 69 Solazed TM 69 nephropathic cystinosis 69 oral beclomethasone dipropionate 69 Initiates Clinical Trial 69 targeted radiotherapeutic 69 delivers fluocinolone acetonide FA 69 essential thrombocythemia ET 69 IAP inhibitors 69 IMiDs ® 69 Personalized Immunotherapy 69 systemic RNAi therapeutic 69 tiapamil 69 methylnaltrexone bromide 69 2 methoxyestradiol 69 relapsed leukemia 69 chronic eosinophilic leukemia 68 polysaccharide polymer 68 ALN PCS 68 oropharyngeal candidiasis OPC 68 hypereosinophilic syndrome 68 refractory chronic lymphocytic 68 Diabetic Macular Edema DME 68 octreotide implant 68 JAK2 inhibitor 68 CINTREDEKIN BESUDOTOX 68 sapropterin dihydrochloride 68 lexidronam injection 68 Zorbtive TM 68 oral prodrug 68 MTP inhibitor 68 Initiate Clinical Trial 68 hyperphenylalaninemia HPA due 68 Initiates Phase II 68 selective modulator 68 myelodysplastic myeloproliferative diseases 68 ALN TTR# 68 Kuvan R 68 complement inhibitor eculizumab 68 Panzem R 68 topically administered 68 Lubiprostone 68 ATL# [002] 68 metastatic malignant 68 cutaneous T 68 lucinactant 68 Xyfid TM 68 R Saizen R 68 dasatinib Sprycel ® 68 stable nucleic acid 68 MOVIPREP R 68 vinca alkaloid 68 Safinamide 67 Iluvien ® 67 PEGylated anti 67 TNF Tumor Necrosis Factor 67 samarium Sm 67 Tezampanel 67 hyaluronidase enzyme 67 ATTR CM 67 Serostim ® 67 polycythemia vera essential thrombocythemia 67 symptomatic benign prostatic 67 NASH Huntington 67 non nucleoside inhibitor 67 malignant ascites 67 alpha1 antitrypsin deficiency 67 Chemokine Receptor 67 human C1 inhibitor 67 Meets Primary Endpoint 67 hyperplasia BPH 67 GW# [003] 67 topically applied SEPA 67 castrate resistant prostate cancer 67 IV Busulfex 67 chronic immune thrombocytopenic 67 targeted nucleotide prodrug 67 microtubule inhibitor 67 Disease IBD 67 Factor Receptor 67 uricase 67 intravesical instillation 67 Bucindolol 67 Saizen ® 67 Pegloticase 67 generation purine nucleoside 67 TKB# 67 acid phosphatase PAP 67 nucleoside analog 67 hormone LHRH antagonist 67 novel VDA molecule 67 histone deacetylase inhibitor 67 dihydrochloride 67 sorafenib tablets 67 Pathway Inhibitor 67 humanized anti 67 TTR amyloidosis 67 proprietary polysaccharide 67 secondary hyperparathyroidism 67 infectious diseases autoimmune diseases 67 IMiDs R 67 rusalatide acetate 67 NS#/#A protease 67 toenail onychomycosis 67 CYT# potent vascular disrupting 67 Serostim R 67 transthyretin TTR mediated amyloidosis 66 exocrine pancreatic insufficiency EPI 66 cell lymphoma CTCL 66 transthyretin amyloidosis 66 small molecule Hedgehog 66 familial amyloidotic polyneuropathy FAP 66 non porcine pancreatic 66 JAK2 Inhibitor 66 Familial Adenomatous Polyposis 66 Enzyme Replacement Therapy 66 CTAP# 66 Luteinizing Hormone Releasing Hormone 66 Phenylketonuria 66 targeted antifolate 66 Drug Candidate 66 peripherally acting 66 Maribavir 66 Aflibercept 66 inhalation powder 66 Onalta 66 chronic granulomatous disease 66 EVIZON TM 66 modified glutathione analog 66 glutamic acid decarboxylase 66 adenosine A2A 66 Begins Dosing 66 Vidaza ® 66 beta 1a 66 Phase 2b Clinical Trial 66 Atypical Hemolytic Uremic Syndrome 66 leukemia AML 66 Receives Orphan Drug Designation 66 huC# DM4 66 Pyridorin TM 66 Azacitidine 66 targets Galectin receptors 66 TELINTRA 66 atypical hemolytic uremic syndrome 66 benign prostatic hypertrophy BPH 66 Diabetic Neuropathy 66 familial hypercholesterolemia FH 66 M2 subunit 66 MEK inhibitor 66 MAGE A3 ASCI 66 Leber Hereditary Optic Neuropathy 66 Romidepsin 66 Phenylketonuria PKU 66 Inhalation Aerosol 66 Initiates Enrollment 66 Immunotherapeutic 66 PNT# 66 chronic myeloid 66 IAP inhibitor 66 Methylnaltrexone 66 Zemiva TM 66 Omacetaxine 66 AVAPRO 66 phenylketonuria PKU 66 RhuDex ® 66 Bronchiectasis 66 thetreatment 66 AGGRASTAT R Injection tirofiban 66 phase III isavuconazole 66 AEG# 66 Orally administered 66 Aurora Kinase 66 Sudhir Agrawal D.Phil 66 Cannabinor 66 Solazed ™ 66 interstitial cystitis IC 66 pouchitis 66 either acutely decompensated 66 Reminyl galantamine 66 cetuximab Erbitux R 66 selective kinase inhibitor 66 Alfacell proprietary ribonuclease 66 Tyrosine Kinase Inhibitor 66 platinum chemotherapeutic 66 TLK# 66 vidofludimus 66 Onalta TM 66 Vidaza azacitidine 66 INS# [001] 65 Chronic Myeloid Leukemia CML 65 Gleevec resistant 65 Aganocide ® 65 Cutaneous T 65 NEBIDO R 65 treat benign prostatic 65 Opterone R 65 oral proteasome inhibitor 65 Gonal f R 65 PEGylated 65 DURIN TM 65 systemic fungal infections 65 fumarate 65 SMARTICLES ® 65 antibody MAb 65 monoclonal antibody conjugated 65 Kuvan TM sapropterin 65 peritumoral brain edema 65 pancreatic insufficiency 65 Completes Patient Enrollment 65 sodium glucose cotransporter 65 VitiGam 65 AAG geldanamycin analog 65 PKC# 65 potently inhibit 65 Initiates Phase III 65 investigational monoclonal antibody 65 Anavex #-# 65 pralatrexate injection folate analogue 65 DELATESTRYL R 65 mertansine 65 refractory gout 65 Pimavanserin 65 Leukemias 65 Onalta ™ 65 ALK inhibitor 65 TKM ApoB 65 PDX pralatrexate 65 Friedreich Ataxia FRDA 65 histone deacetylase HDAC inhibitor 65 Refractory Hodgkin Lymphoma 65 metastatic colorectal 65 LHRH antagonist 65 acadesine 65 Cloretazine 65 Quark Biotech Inc. 65 Soliris eculizumab 65 metastatic neuroendocrine tumors 65 Tumour Vascular Disrupting Agent 65 Lixivaptan 65 iobenguane 65 YONDELIS 65 thalidomide Thalomid 65 FUSILEV enhances 65 soluble tumor necrosis 65 targeting Inflammatory Bowel 65 CD3 monoclonal antibody 65 Vitrasert R 65 tramiprosate 65 erlotinib Tarceva ® 65 Voreloxin 65 nonhuman primate model 65 arthritis PsA 65 oral nucleoside analogue 65 Monoclonal antibody 65 Severe Sepsis 65 tumors GIST 65 XL# XL# 65 Linaclotide 65 Anti VEGF 65 denileukin diftitox 65 pan histone deacetylase 65 RhuDex R 65 ALN HPN 65 Spiegelmer ® 65 IgG1 monoclonal antibody 65 SUPPRELIN R LA 65 molecular imaging radiopharmaceutical 65 itraconazole Sporanox 65 kidney urologic 65 CB2 selective receptor agonist 65 PDE4 inhibitor 65 faropenem medoxomil 65 cetuximab Erbitux ® 65 RNAi therapeutic targeting PCSK9 65 Patients Treated With 65 docetaxel Taxotere ® 65 recurrent glioblastoma multiforme 65 R lenalidomide 65 LHRH receptor positive 65 luteinizing hormone releasing 65 MKC# MT 65 Alferon LDO 65 thiazolides 65 chimeric monoclonal antibody 65 Microplasmin 65 candidates Azedra TM 65 Myelodysplastic Syndrome MDS 65 pseudobulbar affect PBA 65 BCG refractory carcinoma 65 Novel Oral 65 Interferon Beta 65 cysteamine bitartrate 65 dasatinib Sprycel 65 ® lenalidomide 65 carcinoid syndrome 65 selective inhibition 65 Ozarelix 65 mTOR mammalian target 65 gastro intestinal inflammation 65 Onconase 65 inhaled liposomal ciprofloxacin 65 liposomal formulation 65 Oracea TM 65 subependymal giant cell 65 PGL# 65 protein tyrosine phosphatase 1B 65 Peginterferon alfa 2b 65 indinavir Crixivan 65 vWD 65 sodium stibogluconate 65 norepinephrine reuptake inhibitor 65 oral ghrelin agonist 65 anti CD3 65 hypoxia activated prodrug 65 HCV polymerase 65 small molecule thrombopoietin 65 inhibitor RG# 65 Sapacitabine 65 Acute Bacterial Sinusitis ABS 65 JAK1 65 erythematosus 65 2A receptor agonist 65 Initiate Phase 64 Carbamazepine 64 vitreoretinal disorders 64 Cerebril TM 64 5 HT3 antagonist 64 anticancer compound 64 constipation OIC 64 A1PI 64 KSP inhibitor 64 Bezielle 64 psoriasis rheumatoid arthritis 64 Syncria R 64 Silodosin 64 Fabry Disease 64 induced macular edema 64 Pafuramidine 64 oral dual endothelin 64 Leukine ® 64 catheter occlusion 64 cromolyn sodium 64 rHuPH# recombinant human 64 Presents Preclinical 64 EVIZON ™ 64 antisense inhibitors 64 5 fluorouracil leucovorin 64 Decitabine 64 THR beta agonist 64 non nucleoside 64 XL# anticancer compounds 64 Daclizumab 64 alpha1 antitrypsin AAT deficiency 64 E1 INT TM 64 Lenocta 64 dihydrochloride Tablets 64 abacavir Ziagen 64 somatostatin analogue 64 proteasome inhibitor 64 immunocompetent patients 64 purpura ITP 64 treat hyperphosphatemia 64 adalimumab Humira 64 anti CD3 antibody 64 nephropathic cystinosis cystinosis 64 EVIZON TM squalamine lactate 64 R#/MEM # 64 CD# expressing 64 AKT inhibitor 64 GLP1 INT TM 64 prokinetic agent 64 Archexin 64 acute peripheral arterial 64 immuno modulatory 64 proliferator activated receptor 64 primary dysmenorrhea 64 Deferiprone 64 Chronic lymphocytic leukemia 64 Fibrillex TM 64 Li Fraumeni Syndrome 64 Eprodisate 64 accumulate preferentially 64 investigational humanized monoclonal antibody 64 diabetic gastroparesis 64 imatinib Gleevec ® 64 XYOTAX TM 64 Proxinium TM 64 metaglidasen 64 induced mucositis 64 Enzastaurin 64 Velcade bortezomib 64 CTAP# Capsules 64 histone deacetylase HDAC inhibitors 64 ADAMTS# 64 severe malignant osteopetrosis 64 Panzem ® 64 OMP #R# 64 FDA APPROVES 64 rxRNA 64 targeting PCSK9 64 receptor tyrosine kinase inhibitor 64 anti inflammatory NSAID 64 chemotherapy induced neutropenia 64 Hepatitis C virus HCV 64 Primary Hypercholesterolemia 64 inhibitor PPI 64 investigational pharmacologically unique 64 receptor partial agonist 64 isoform selective 64 therapeutically inactive prodrug 64 Bremelanotide 64 overactive bladder syndrome 64 SinuNase TM 64 treat nephropathic cystinosis 64 RNAi Therapeutic 64 AA amyloidosis 64 vascular disrupting agents 64 herpetic keratitis 64 HP Acthar Gel repository 64 NeuroSTAT ® 64 investigational antiplatelet agent 64 chemosensitizer 64 CCR5 antagonist 64 Presents Preclinical Data 64 ATL# [001] 64 Chemophase 64 Dacogen decitabine 64 oral Janus kinase 64 selective immunoproteasome inhibitor 64 HDAC Inhibitor 64 EP #R 64 Transdermal Patch 64 Morquio 64 Initiates Clinical 64 selective A2A adenosine receptor 64 novel therapeutic antibodies 64 CMV vaccine 64 homozygous FH 64 secondary amenorrhea 64 MyVax ® 64 prescribed proton pump 64 Factor VIIa 64 sodium thiosulfate STS 64 Protein Kinase C 64 bevacizumab Avastin ® 64 novel immunomodulatory 64 prostanoid 64 vapreotide acetate 64 INSPIRE Trial Phase III 64 acute intermittent porphyria 64 gastrointestinal stromal tumors GIST 64 Hepatitis C Virus HCV 64 IMiDs ® compound 64 carcinoma HCC 64 Elagolix 64 Replacement Therapy 64 cystic fibrosis chronic pancreatitis 64 HepDirect prodrug 64 Phase 2a Clinical Trial 64 2 inhibitor CYT# 64 Gel repository corticotropin injection 64 Submits NDA 64 ADPKD 64 triggers apoptosis programmed 64 polycythemia vera PV 64 selective adenosine 64 Cytarabine 64 gemcitabine Gemzar R 64 topical gel formulation 64 Annamycin 64 Kit CD# positive 64 sirtuin inhibitor program 64 Empatic TM 64 Prodrug 64 HBeAg negative 64 ALTROPANE R 64 leukemia CLL 64 chronic idiopathic thrombocytopenic purpura 64 R metformin Concor 64 CCR1 64 Angiotensin Converting Enzyme 64 PrevOnco 64 selective antagonist 64 Kamada AAT 64 dipropionate 64 Ridaforolimus 64 Mipomersen 64 NAGS deficiency 64 5 HT4 63 Nexavar sorafenib 63 Alinia 63 sitaxsentan 63 Duchenne muscular dystrophy DMD 63 trial evaluating PRX# 63 KRN# 63 syngeneic 63 dyskinesia PD LID 63 HeFH 63 Calcitonin 63 postoperative ileus 63 candidate deforolimus 63 CYP#A# CYP#D# 63 primary hyperparathyroidism 63 N acetylgalactosamine 6 63 platform HDL Mimetic 63 Enkephalin 63 Reports Preclinical Data 63 Parkinson disease levodopa induced 63 commercialize deforolimus 63 recombinant subunit vaccine 63 Lymphocytic 63 idiopathic thrombocytopenic purpura ITP 63 plasmid encoding 63 Unit Dose Budesonide 63 Vicinium TM 63 SNT-MC#/idebenone 63 ATPace TM 63 Sprycel dasatinib 63 anti CD3 monoclonal 63 specifically hypoactive sexual 63 Metastatic Melanoma 63 Albugon 63 AVONEX ® 63 candidates Azedra 63 virus HCV protease inhibitor 63 diabetic macular edema DME 63 ATG Fresenius S 63 targeting CD# 63 Denufosol 63 Degarelix 63 TÎ ² 4 63 Phase IIa Clinical Trial 63 drug ISA# 63 autoimmune uveitis 63 Presents Positive 63 PD LID 63 SPRYCEL ® 63 rare autosomal recessive 63 investigational atypical antipsychotic 63 MyVax R 63 cause cardiac channelopathies 63 hormone agonist 63 treat male hypogonadism 63 rasagiline tablets 63 systemic juvenile idiopathic 63 relapsed ALL 63 RhuDex TM 63 delivered RNAi therapeutic 63 bladder ovarian 63 Irinotecan 63 siRNA therapeutic 63 fibrotic disorders 63 Trodusquemine MSI 63 Epstein Barr Virus EBV 63 radiotherapeutic 63 BUPHENYL 63 Pivotal Phase III 63 PF # [002] 63 R sorafenib tablets 63 CIMZIA TM certolizumab pegol 63 Ribavirin causes 63 product platforms AZX# 63 potent antiproliferative 63 syndrome gastroesophageal reflux 63 GTC recombinant human 63 INCB# [003] 63 iSONEP TM 63 non splenectomized 63 Dose Ranging Study 63 5 FU leucovorin 63 engineered RAP peptides 63 therapeutic monoclonal antibodies 63 Aryplase 63 telomerase therapeutic 63 Parathyroid Hormone 63 aripiprazole Abilify 63 Solazed 63 Files IND 63 orally inhaled 63 pan genotypic 63 mixed hyperlipidemia 63 Therapeutic Vaccine 63 Granulocyte Colony Stimulating Factor 63 vaginal candidiasis 63 Zenvia ™ 63 Inhalation Solution 63 pafuramidine maleate 63 myeloproliferative disorders 63 RNA antagonist 63 R roscovitine CDK cyclin 63 Mutation Analysis 63 echinocandin 63 alefacept 63 Lymphoid 63 Polyneuropathy 63 polymerase inhibitor 63 thromboxane A2 63 include PLX IBD 63 RAV# 63 reslizumab 63 developing Zerenex ferric 63 Thrombin 63 OMNARIS HFA 63 post transplant lymphoproliferative 63 Cancidas 63 Vandetanib 63 thrombolytic agent 63 Janus kinase 63 Kuvan sapropterin dihydrochloride 63 PLK1 SNALP 63 liposomal delivery 63 Bazedoxifene 63 BRAF mutant 63 Glioblastoma Multiforme 63 signal transduction inhibitors 63 antimetabolite 63 Sevelamer 63 Atopic Dermatitis 63 Phase IIb Clinical Trial 63 Phase 2b Study 63 HGS ETR1 mapatumumab 63 Dalbavancin 63 ketolide antibiotic 63 Philadelphia Chromosome Positive 63 Vaprisol 63 Zenapax 63 replicon 63 Altropane 63 refractory cutaneous T 63 allosteric modulator NAM 63 forodesine 63 RNA antagonists 63 rhIGF-I/rhIGFBP-3 63 mGluR2 positive 63 refractory acute myeloid 63 Epidermal Growth Factor Receptor 63 Granted Orphan Drug 63 delta gamma agonist 63 DOS# 63 Anturol ® 63 ADL# novel 63 alkylating agent 63 Iluvien TM 63 SNT MC# 63 sulfatase 63 rheumatoid arthritis RA psoriatic 63 XIAFLEX ™ 63 trastuzumab DM1 T DM1 63 investigational anaplastic lymphoma kinase 63 ASONEP ™ 63 YONDELIS R 63 neuropathic pain spasticity 63 acyclovir Lauriad R 63 modulator SERM 63 melanocortin receptor agonists 63 Antiangiogenic 63 terlipressin 63 Carbidopa 63 anti PlGF 63 idiopathic pulmonary fibrosis IPF 63 TNF Blockers 63 Genotyping Test 63 etanercept Enbrel 63 idiopathic thrombocytopenic purpura 63 RTP #i 63 refractory prostate cancer 63 lymphoid malignancies 63 advanced metastatic renal 63 metastatic hormone refractory 63 neurogenic bladder 63 DepoCyt 63 cisplatin gemcitabine 63 dextromethorphan quinidine 63 Phase 2b Trial 63 cholesteryl ester transfer 63 vaccine GRNVAC1 63 Parnate 63 Carcinoid tumors 63 metastatic GIST 63 G6PD deficiency 63 metastatic gastric 63 Naive Patients 63 pancreatic enzyme replacement 63 QUADRAMET R 63 lead molecular radiotherapeutic 63 sapropterin dihydrochloride Tablets 63 hormone refractory metastatic prostate 63 neovascular diseases 63 Nebulized 63 Preclinical studies suggest 63 ATTR 63 MELAS 63 Bendamustine 63 Vascugel 63 Mycophenolate Mofetil 63 MKC# MKC# PP 63 Darinaparsin 63 Panzem 63 Homspera TM 63 autologous cellular immunotherapy 63 humanized antibody 63 CYT# QbG# 63 NU# direct 63 nucleotide analog 63 Maxy G# 63 NPC 1C 63 sorafenib Nexavar 63 aurora kinase 63 vinorelbine tartrate 63 novel histone deacetylase 63 Solesta TM 63 Ataluren 63 Xanafide 63 miconazole Lauriad ® 63 mGluR2 NAM 63 PKU genetic 63 pulmonary hypertension PH 63 CD# CEA 63 cyclin dependent kinase inhibitor 63 Vidaza R 63 GVAX ® 63 oral dihydropyrimidine dehydrogenase DPD 63 Eculizumab 63 adult mesenchymal stem 63 volociximab 63 Cellegesic 63 using VIAdel TM 63 anti secretory 63 intestinal polyps 63 topical ophthalmic 63 VALSTAR R 63 selective phosphodiesterase 63 metastatic carcinoid 63 Aliskiren 63 NeoLipid R 63 immuno inflammatory diseases 62 Frozen Shoulder syndrome Adhesive 62 OHR/AVR# 62 collagen vascular 62 Dupuytren Contracture 62 ELADUR ™ 62 Chronic Lymphocytic Leukemia CLL 62 Non Alcoholic Steatohepatitis 62 Ovitrelle R Serostim 62 Systemic lupus erythematosus SLE 62 AGHD 62 irinotecan oxaliplatin 62 congenital ichthyosis 62 lomitapide 62 hypoxia inducible factor 62 gefitinib Iressa 62 HSP# inhibitor 62 Actimmune ® 62 Receives Orphan Drug 62 % uracil topical 62 TO AVOID PREGNANCY WHILE 62 von Hippel Lindau 62 Neovascular Age Related Macular 62 neovascular wet age 62 Idiopathic Pulmonary Fibrosis 62 DDP# 62 ergot derivatives 62 mutated K ras 62 Aplidin R 62 brivanib 62 candidate REP# 62 including thyroiditis RA 62 evaluating picoplatin 62 Polymorphic Ventricular Tachycardia CPVT 62 neuropathic pain metabolic diseases 62 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 62 TRIOLEX HE# APOPTONE HE# 62 Evoltra ® 62 LymphoStat B belimumab 62 MET VEGFR2 62 KL4 Surfactant 62 Preclinical Study 62 ara C 62 generation antisense inhibitor 62 Initiates Clinical Trials 62 Glypromate 62 Regenerative Cells 62 LibiGel ® 62 T#I [002] 62 Acute Exacerbations 62 Squamous 62 Diabetic Macular Edema 62 Chronic Myeloid Leukemia 62 NeoLipid TM 62 Oncolytic 62 romazarit 62 NMDA antagonist 62 Piperacillin 62 IND Application 62 Soriatane 62 Pyridorin 62 Azedra 62 anti botulism antibody 62 Orphan Status 62 unresectable tumors 62 Bosutinib 62 cell carcinoma RCC 62 gastrointestinal stromal tumor GIST 62 BCR ABL inhibitors 62 GCase 62 Genentech Rituxan 62 Tasimelteon 62 pentostatin 62 myeloid metaplasia 62 rheumatoid arthritis osteoarthritis ankylosing 62 M# rationally 62 INTEGRILIN R 62 Cloretazine ® 62 TBC# 62 Cethromycin 62 JAK inhibitor 62 systemic immunosuppressive drugs 62 Cleviprex TM clevidipine 62 ALVESCO ® 62 optimal dosing regimens 62 cancer cachexia 62 late infantile neuronal 62 Adenoviral 62 myelofibrosis polycythemia vera 62 Junovan TM 62 Hsp# Inhibitor 62 Genasense ® oblimersen 62 TTR gene 62 Leber Congenital Amaurosis LCA 62 psoriasis vulgaris 62 MKC# 62 Androxal TM 62 antibody MT# 62 Investigational Oral 62 Pulmonary Arterial Hypertension 62 autosomal dominant polycystic kidney 62 polymerase inhibitors 62 alvespimycin 62 Vascular Disrupting Agent 62 pathophysiological effects 62 Fx #A 62 Initiates Phase 2b 62 Receptors GPCRs 62 2DG 62 Vicriviroc 62 tuberous sclerosis TS 62 selective androgen receptor modulator 62 candidate XP# 62 murine model 62 TG# [003] 62 Eltrombopag 62 SGPT 62 Interferon beta 62 Noxafil 62 Gemzar gemcitabine 62 vesicoureteral reflux VUR malformation 62 taxane resistant 62 HQK 62 C1 INH deficiency 62 idiopathic myelofibrosis 62 DiLA2 62 Benign Prostatic Hyperplasia 62 HuCNS SC ® 62 Myolimus 62 Cathepsin S 62 Proquin XR 62 TACI Ig 62 Wafer polifeprosan 62 Phenoptin 62 clotrimazole 62 corticosteroid dexamethasone 62 Phase III Pivotal 62 Oral Spray 62 vivo validation 62 CDK inhibitor 62 Convivia TM 62 Pemetrexed 62 myeloproliferative neoplasms 62 Successfully Completes Phase 62 PYY #-# 62 Retinoic Acid 62 Xcytrin R 62 acute mania 62 tafamidis 62 aldehyde dehydrogenase ALDH2 deficiency 62 GRNOPC1 contains 62 therapeutic monoclonal antibody 62 overactive bladder AA# 62 hemorrhagic cystitis 62 ZYBRESTAT TM 62 Hedgehog Pathway Inhibitor 62 5 HT2A inverse 62 CA4P 62 novel prodrug 62 ABILIFY ® 62 Mitoxantrone 62 Gamunex C 62 relapsed MM 62 cyclophilin inhibitors 62 potent inducer 62 LEUKINE 62 Aganocide 62 immunomodulators 62 BXT # 62 lysosomal storage disorder 62 Actinic Keratosis 62 Tigecycline 62 EZN 62 Cx# [002] 62 nebulized budesonide 62 Sustiva efavirenz 62 lintuzumab SGN 62 sublingual tablets 62 oncolytic virus therapies 62 iSONEP ™ 62 Major Depressive Disorder MDD 62 HCV protease inhibitors 62 Intravenous Human 62 Li Fraumeni 62 treat lupus renal 62 calcineurin inhibitor 62 DIFICID ™ 62 personalized cellular immunotherapy 62 mitogen activated ERK kinase 62 humanized monoclonal antibodies 62 TELINTRA R 62 proliferative disorders 62 Progressive Multifocal Leukoencephalopathy 62 Cytochrome P# 62 AQ4N 62 Liposomal 62 interferon gamma 1b 62 prostone 62 systemic anaplastic large 62 NS5b 62 R bisoprolol Euthyrox 62 interleukin IL -# 62 nasal calcitonin product 62 forodesine hydrochloride 62 Hemophilia B 62 Advanced Renal Cell 62 paclitaxel Taxol R 62 anti amnesic 62 mecasermin 62 orally administered synthetic retinoid 62 immunotoxins 62 inhaled AAT 62 Systemic Sclerosis 62 OMP #M# 62 phase IIb clinical 62 Hypoactive Sexual Desire Disorder 62 Traficet EN 62 Recombinant interferon alpha 62 LIALDA TM 62 systemically administered 62 amikacin 62 Alocrest 62 basiliximab 62 nucleotide analogue 62 opioid induced constipation 62 metastatic castrate resistant 62 Viprovex TM 62 transplantation HCT 62 Azathioprine 62 depsipeptide 62 Prolastin C 62 LymphoStat B TM 62 Besivance 62 Rhucin ® recombinant 62 Gaucher Disease 62 TYZEKA 62 benzimidazole 62 novel emulsion formulation 62 Omalizumab 62 ThermoDox R 62 situ CIS 62 Melphalan 62 immunomodulatory properties 62 huN# DM1